• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 病毒成熟过程中的 Gag-Pol 加工:一种系统生物学方法。

Gag-Pol processing during HIV-1 virion maturation: a systems biology approach.

机构信息

Institute of Biology, Eötvös Loránd University, Budapest, Hungary.

出版信息

PLoS Comput Biol. 2013;9(6):e1003103. doi: 10.1371/journal.pcbi.1003103. Epub 2013 Jun 6.

DOI:10.1371/journal.pcbi.1003103
PMID:23754941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3675044/
Abstract

Proteolytic processing of Gag and Gag-Pol polyproteins by the viral protease (PR) is crucial for the production of infectious HIV-1, and inhibitors of the viral PR are an integral part of current antiretroviral therapy. The process has several layers of complexity (multiple cleavage sites and substrates; multiple enzyme forms; PR auto-processing), which calls for a systems level approach to identify key vulnerabilities and optimal treatment strategies. Here we present the first full reaction kinetics model of proteolytic processing by HIV-1 PR, taking into account all canonical cleavage sites within Gag and Gag-Pol, intermediate products and enzyme forms, enzyme dimerization, the initial auto-cleavage of full-length Gag-Pol as well as self-cleavage of PR. The model allows us to identify the rate limiting step of virion maturation and the parameters with the strongest effect on maturation kinetics. Using the modelling framework, we predict interactions and compensatory potential between individual cleavage rates and drugs, characterize the time course of the process, explain the steep dose response curves associated with PR inhibitors and gain new insights into drug action. While the results of the model are subject to limitations arising from the simplifying assumptions used and from the uncertainties in the parameter estimates, the developed framework provides an extendable open-access platform to incorporate new data and hypotheses in the future.

摘要

Gag 和 Gag-Pol 多蛋白的蛋白水解加工由病毒蛋白酶(PR)完成,这对产生感染性 HIV-1 至关重要,病毒 PR 的抑制剂是当前抗逆转录病毒疗法的重要组成部分。该过程具有多个层次的复杂性(多个切割位点和底物;多种酶形式;PR 自身加工),这需要采用系统级方法来确定关键弱点和最佳治疗策略。在这里,我们提出了第一个完整的 HIV-1 PR 蛋白水解加工的全反应动力学模型,该模型考虑了 Gag 和 Gag-Pol 内的所有规范切割位点、中间产物和酶形式、酶二聚化、全长 Gag-Pol 的初始自身切割以及 PR 的自身切割。该模型使我们能够确定病毒成熟的限速步骤以及对成熟动力学影响最强的参数。使用建模框架,我们预测了个体切割率与药物之间的相互作用和补偿潜力,描述了该过程的时间过程,解释了与 PR 抑制剂相关的陡峭剂量反应曲线,并深入了解了药物作用。虽然模型的结果受到所使用的简化假设和参数估计不确定性的限制,但所开发的框架为将来纳入新数据和假设提供了一个可扩展的开放访问平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/645897961a2b/pcbi.1003103.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/fbbff143ccd2/pcbi.1003103.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/f406a9dc4a49/pcbi.1003103.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/3cf0518ed68b/pcbi.1003103.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/a3956daf64e6/pcbi.1003103.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/7e24bda9169b/pcbi.1003103.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/3d6b481965d3/pcbi.1003103.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/5e2062a46ed3/pcbi.1003103.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/645897961a2b/pcbi.1003103.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/fbbff143ccd2/pcbi.1003103.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/f406a9dc4a49/pcbi.1003103.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/3cf0518ed68b/pcbi.1003103.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/a3956daf64e6/pcbi.1003103.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/7e24bda9169b/pcbi.1003103.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/3d6b481965d3/pcbi.1003103.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/5e2062a46ed3/pcbi.1003103.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65da/3675044/645897961a2b/pcbi.1003103.g008.jpg

相似文献

1
Gag-Pol processing during HIV-1 virion maturation: a systems biology approach.HIV-1 病毒成熟过程中的 Gag-Pol 加工:一种系统生物学方法。
PLoS Comput Biol. 2013;9(6):e1003103. doi: 10.1371/journal.pcbi.1003103. Epub 2013 Jun 6.
2
Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.在 HIV-1 Gag 和 Gag-Pro-Pol 多蛋白前体中,病毒蛋白酶对一组加工位点的切割速率的确定,周围的环境(context)是至关重要的。
J Biol Chem. 2012 Apr 13;287(16):13279-90. doi: 10.1074/jbc.M112.339374. Epub 2012 Feb 13.
3
trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.反式作用病毒蛋白酶对于禽白血病病毒逆转录酶的激活是必需且充分的。
J Virol. 1991 Nov;65(11):6218-31. doi: 10.1128/JVI.65.11.6218-6231.1991.
4
Induced maturation of human immunodeficiency virus.人类免疫缺陷病毒的诱导成熟
J Virol. 2014 Dec;88(23):13722-31. doi: 10.1128/JVI.02271-14. Epub 2014 Sep 17.
5
HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.HIV-1 逆转录酶稳定性与 Gag 切割效率相关:逆转录酶相互作用对调节蛋白酶激活的意义。
J Virol. 2023 Sep 28;97(9):e0094823. doi: 10.1128/jvi.00948-23. Epub 2023 Sep 6.
6
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?人类免疫缺陷病毒1型C亚型蛋白酶切割位点的变异性:病毒适应性的一种指征?
J Virol. 2003 Sep;77(17):9422-30. doi: 10.1128/jvi.77.17.9422-9430.2003.
7
Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.在昆虫细胞中表达的禽白血病病毒Gag-Pol融合蛋白的逆转录酶和蛋白酶活性。
J Virol. 1993 Dec;67(12):7582-96. doi: 10.1128/JVI.67.12.7582-7596.1993.
8
Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.维持Gag/Gag-Pol比率对于1型人类免疫缺陷病毒的RNA二聚化和病毒感染性很重要。
J Virol. 2001 Feb;75(4):1834-41. doi: 10.1128/JVI.75.4.1834-1841.2001.
9
HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.HIV-1 蛋白酶 N 端融合亮氨酸拉链后表现出增强的连接氨基酸依赖性活性。
Retrovirology. 2018 Apr 14;15(1):32. doi: 10.1186/s12977-018-0413-6.
10
Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package.降低 gag 裂解效率对 HIV-1 Gag-Pol 包装的影响。
BMC Microbiol. 2022 Apr 9;22(1):94. doi: 10.1186/s12866-022-02503-3.

引用本文的文献

1
Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo.慢病毒载体假型化用于体内细胞特异性基因递送的研究进展
Viruses. 2025 May 31;17(6):802. doi: 10.3390/v17060802.
2
Modeling and Analysis of HIV-1 Pol Polyprotein as a Case Study for Predicting Large Polyprotein Structures.HIV-1 Pol 多聚蛋白建模与分析:以预测大型多蛋白结构为例
Int J Mol Sci. 2024 Feb 2;25(3):1809. doi: 10.3390/ijms25031809.
3
Molecular dynamics simulations of HIV-1 matrix-membrane interactions at different stages of viral maturation.

本文引用的文献

1
Kinetic characterization of the critical step in HIV-1 protease maturation.HIV-1 蛋白酶成熟过程中关键步骤的动力学特征。
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20449-54. doi: 10.1073/pnas.1210983109. Epub 2012 Nov 26.
2
The choreography of HIV-1 proteolytic processing and virion assembly.HIV-1 蛋白水解加工和病毒装配的协调作用。
J Biol Chem. 2012 Nov 30;287(49):40867-74. doi: 10.1074/jbc.R112.399444. Epub 2012 Oct 5.
3
Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy.
HIV-1 基质-膜相互作用在病毒成熟不同阶段的分子动力学模拟。
Biophys J. 2024 Feb 6;123(3):389-406. doi: 10.1016/j.bpj.2024.01.006. Epub 2024 Jan 9.
4
The C-Terminal Domain of RNase H and the C-Terminus Amino Acid Residue Regulate Virus Release and Autoprocessing of a Defective HIV-1 Possessing M50I and V151I Changes in Integrase.RNase H 的 C 末端结构域和 C 末端氨基酸残基调节具有 M50I 和 V151I 整合酶变化的缺陷 HIV-1 的病毒释放和自身切割。
Viruses. 2022 Nov 30;14(12):2687. doi: 10.3390/v14122687.
5
Sequence dependencies and biophysical features both govern cleavage of diverse cut-sites by HIV protease.序列依赖性和生物物理特征共同控制 HIV 蛋白酶对多种切割位点的切割。
Protein Sci. 2022 Jul;31(7):e4366. doi: 10.1002/pro.4366.
6
Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness.对处于生存阈值的HIV蛋白酶变体的分析揭示了加工效率与适应性之间的关系。
Virus Evol. 2021 Dec 14;7(2):veab103. doi: 10.1093/ve/veab103. eCollection 2021 Sep.
7
Dynamics of HIV-1 Gag Processing as Revealed by Fluorescence Lifetime Imaging Microscopy and Single Virus Tracking.荧光寿命成像显微镜和单病毒跟踪揭示的 HIV-1 Gag 加工动力学。
Viruses. 2022 Feb 8;14(2):340. doi: 10.3390/v14020340.
8
The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation.HIV-1 衣壳蛋白通过相分离活性增强来调节自身的浓缩,从而在成熟过程中隔离病毒蛋白酶。
Viruses. 2021 Nov 19;13(11):2312. doi: 10.3390/v13112312.
9
Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing.HIV-1 整合酶和 RNase H 中的天然存在的多态性调节病毒释放和自身加工。
J Virol. 2021 Nov 9;95(23):e0132321. doi: 10.1128/JVI.01323-21. Epub 2021 Sep 15.
10
Reconstruction of Microbial Haplotypes by Integration of Statistical and Physical Linkage in Scaffolding.通过在支架中整合统计和物理连锁信息重建微生物单倍型。
Mol Biol Evol. 2021 May 19;38(6):2660-2672. doi: 10.1093/molbev/msab037.
冷冻电镜下 8Å 分辨率的不成熟逆转录病毒衣壳结构。
Nature. 2012 Jul 19;487(7407):385-9. doi: 10.1038/nature11169.
4
Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.调节 HIV-1 Gag NC/p1 切割效率会影响蛋白酶抑制剂耐药性和病毒复制能力。
Retrovirology. 2012 Apr 1;9:29. doi: 10.1186/1742-4690-9-29.
5
Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion.HIV-1 通过病毒学突触的细胞间转移导致内体病毒成熟,从而激活病毒膜融合。
Cell Host Microbe. 2011 Dec 15;10(6):551-62. doi: 10.1016/j.chom.2011.10.015.
6
Cell-to-Cell Spread of Retroviruses.逆转录病毒的细胞间传播。
Viruses. 2010 Jun;2(6):1306-1321. doi: 10.3390/v2061306. Epub 2010 Jun 10.
7
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.HIV 感染者中每日一次服用达芦那韦/利托那韦和每日一次及两次服用雷特格韦的血浆和细胞内药代动力学。
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):450-7. doi: 10.1097/QAI.0b013e3182364c67.
8
Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy.病毒周期动力学影响抗逆转录病毒治疗的药效动力学。
Biol Direct. 2011 Sep 12;6:42. doi: 10.1186/1745-6150-6-42.
9
HIV type 1 Gag as a target for antiviral therapy.1型人类免疫缺陷病毒群抗原作为抗病毒治疗的靶点。
AIDS Res Hum Retroviruses. 2012 Jan;28(1):54-75. doi: 10.1089/AID.2011.0230. Epub 2011 Sep 21.
10
Reaction kinetics of catalyzed competitive heteropolymer cleavage.催化竞争杂多酸裂解的反应动力学。
J Phys Chem B. 2011 Sep 22;115(37):11017-27. doi: 10.1021/jp206321b. Epub 2011 Aug 26.